Radeva, L.; Zaharieva, M.M.; Spassova, I.; Kovacheva, D.; Pencheva-El Tibi, I.; Najdenski, H.; Yoncheva, K.
Biopolymeric Nanogel as a Drug Delivery System for Doxorubicin—Improved Drug Stability and Enhanced Antineoplastic Activity in Skin Cancer Cells. Pharmaceuticals 2024, 17, 186.
https://doi.org/10.3390/ph17020186
AMA Style
Radeva L, Zaharieva MM, Spassova I, Kovacheva D, Pencheva-El Tibi I, Najdenski H, Yoncheva K.
Biopolymeric Nanogel as a Drug Delivery System for Doxorubicin—Improved Drug Stability and Enhanced Antineoplastic Activity in Skin Cancer Cells. Pharmaceuticals. 2024; 17(2):186.
https://doi.org/10.3390/ph17020186
Chicago/Turabian Style
Radeva, Lyubomira, Maya M. Zaharieva, Ivanka Spassova, Daniela Kovacheva, Ivanka Pencheva-El Tibi, Hristo Najdenski, and Krassimira Yoncheva.
2024. "Biopolymeric Nanogel as a Drug Delivery System for Doxorubicin—Improved Drug Stability and Enhanced Antineoplastic Activity in Skin Cancer Cells" Pharmaceuticals 17, no. 2: 186.
https://doi.org/10.3390/ph17020186
APA Style
Radeva, L., Zaharieva, M. M., Spassova, I., Kovacheva, D., Pencheva-El Tibi, I., Najdenski, H., & Yoncheva, K.
(2024). Biopolymeric Nanogel as a Drug Delivery System for Doxorubicin—Improved Drug Stability and Enhanced Antineoplastic Activity in Skin Cancer Cells. Pharmaceuticals, 17(2), 186.
https://doi.org/10.3390/ph17020186
